Hidradenitis suppurativa (HS) Learning Zone
Expert opinion
Watch Dr Joslyn Kirby discussing the latest insights in hidradenitis suppurativa (HS) surrounding:
- The impact, progression and pathophysiology of HS
- Unmet needs in HS diagnosis and treatment
- Treatment options and the evolving treatment landscape
Raising awareness: A call to action
Pathophysiology and risk factors
The immune system in HS pathophysiology
Genetics and environmental triggers in HS risk
Severity and progression risk: A highly variable disease
Burden of disease for people with HS
The physical and psychological impact of HS
Diagnostic and treatment challenges
Treatment of HS
HS treatment goals
Current treatment strategy for HS
Emerging treatment approaches for HS
From bench to clinic: Facilitating individualised treatment
Meet Dr Joslyn Kirby
Updates in your area
of interest
of interest
Articles your peers
are looking at
are looking at
Bookmarks
saved
saved
Days to your
next event
next event
This content has been developed independently by Medthority who previously received educational funding from Novartis Pharma AG in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.